Corporate Finance

With a new CEO known for scaling tech giants, Planview is doubling down on its AI-first platform to dominate the strategic portfolio management market.

For the second straight year, EZ Texting's win of the TrustRadius Buyer's Choice award shows how authentic user reviews are becoming the ultimate tech benchmark.

The global asset manager appoints Kikuo Shirose to lead its Japan office, signaling a deep push into the nation's booming real assets and alternatives market.

Dogtopia is equipping dogs with activity monitors in all its daycares, giving owners unprecedented insight into their pet's health and well-being.

Teal Health's FDA-authorized Teal Wand is now available in all 50 states, aiming to revolutionize preventive care for millions of overdue women.

Omaha-based Core Bank partners with Kobalt Labs, using AI to slash risk review times from days to minutes and safely accelerate its embedded banking strategy.

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

A $7M auction saw a Purdey gun fetch $209K, revealing a red-hot market where history, craftsmanship, and investment potential drive record prices.

Blockchain firm BTCS reports 290% revenue growth, pioneering a new model that blends DeFi with public markets to build an Ethereum powerhouse.

Wearable Devices and Rokid partner to bring touchless gesture control to smart glasses, promising a future where a flick of a finger runs your world.

As Harmony Biosciences presents at JPM, investors will scrutinize its strategy for sustaining growth beyond its star drug and advancing its rare disease pipeline.

Instead of selling out, the family-owned natural products giant is making its 1,800 employees owners, securing a legacy of independence and community focus.

Palisade Bio's PALI-2108, a drug targeting IBD at its source, secures a key investment, offering hope for a new era of treatment with fewer side effects.

With $16.4M in new funding, STRM.BIO is advancing a novel gene therapy platform that uses natural vesicles to target bone marrow, offering new hope for rare diseases.

A new global study shows consumers embrace AI for product research but don't trust it for purchases, revealing a 'Confidence Economy' ruled by transparency.

A new partnership brings a complex wealth-building insurance product to the digital age, offering instant decisions and no medical exams. Is this the future?

Fresh off its 'Fierce 15' win, Recludix Pharma and its billion-dollar Sanofi pact take the spotlight with a novel oral drug for inflammatory diseases.

Universal Insurance Holdings announces a new $20M stock buyback, signaling strong financial health and confidence amidst a stabilizing Florida market.

A new joint venture provides crucial short-term loans, aiming to unlock permanent financing for affordable housing projects facing a critical funding gap.

With a massive $200M Series C, Soley Therapeutics is using its AI cell-sensing platform to fast-track novel cancer drugs from code to clinic.